(Q35125761)

6 August 2017

title

Optimizing the long-term outcome of renal transplants: opportunities created by sirolimus (English)

1 reference

6 August 2017

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00236-7

1 January 2024

author name string

J. R. Chapman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742470

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0041134503002367?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0041-1345(03)00236-7

https://api.elsevier.com/content/article/PII:S0041134503002367?httpAccept=text/plain

1 January 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0041-1345(03)00236-7

Transplantation Proceedings

1 January 2024

published in

1 reference

6 August 2017

volume

35

1 reference

6 August 2017

issue

3 Suppl

1 reference

6 August 2017

page(s)

67S-72S

1 reference

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Reversibility of cyclosporin nephrotoxicity after three months' treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Factors influencing long-term graft loss. The Collaborative Transplant Study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Predictors of renal transplant histology at three months

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900236-7

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference